Screener
Emergent Biosolutions EBS Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Emergent Biosolutions in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent.
The source filing: Emergent Biosolutions’s 10-Q, filed August 6, 2026.
- Filed
- Aug 5, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001367644-26-000082
| Leases | Classification | June 30, 2026 | December 31, 2025 |
|---|---|---|---|
| Operating lease right-of-use assets | Other assets | $5.8 | $10.6 |
| Operating lease liabilities, current portion | Other current liabilities | $1.5 | $2.4 |
| Operating lease liabilities | Other liabilities | 4.9 | 9.2 |
| Total operating lease liabilities | $6.4 | $11.6 | |
| Operating leases: | |||
| Weighted average remaining lease term (years) | 5.1 | 5.2 | |
| Weighted average discount rate | 7.9% | 6.5% |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Emergent Biosolutions's operating lease ROU assets?
- Emergent Biosolutions (EBS) reported operating lease ROU assets of 7.9% in Q2 2026.
- How has Emergent Biosolutions's operating lease ROU assets changed year-over-year?
- Emergent Biosolutions's operating lease ROU assets decreased by 1.3% year-over-year, from 8% to 7.9%.
- What is the long-term trend for Emergent Biosolutions's operating lease ROU assets?
- Over 5 years (2020 to 2025), Emergent Biosolutions's operating lease ROU assets has grown at a 9.7% compound annual growth rate (CAGR), from 4.1% to 6.5%.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.
Ask your AI about Emergent Biosolutions's operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude